Rivaroxaban Plasma Levels and Levetiracetam: A Case Report

Animal studies suggest levetiracetam acts as a P-glycoprotein inducer to reduce rivaroxaban plasma levels. This paper presents first reported case of levetiracetam affecting rivaroxaban plasma levels in a human, leading to clinically important reduction in anticoagulation effect


Annals of Internal Medicine